Recombinant Human IL-17A, Biotinylated Protein Summary
Product Specifications
Gly24-Ala155
Analysis
Product Datasheets
BT7955/CF (carrier free)
Discontinued Product
BT7955
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS and NaCl with BSA as a carrier protein. |
Reconstitution | Reconstitute at 100 μg/mL in PBS containing at least 0.1% human or bovine serum albumin. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: |
Scientific Data
Both Biotinylated Recombinant Human IL-17A (Catalog # BT7955) and unlabeled Recombinant Human IL-17A (Catalog # 7955-IL) induces IL-6 secretion by NIH‑3T3 mouse embryonic fibroblast cells. The ED50 for this effect is 1.5-7.5 ng/mL. The similarity in activity highlights that the biotinylated protein is fully functional.
Reconstitution Calculator
Background: IL-17/IL-17A
Interleukin-17A (IL-17A), also known as CTLA-8, is a 15-20 kDa glycosylated cytokine that plays an important role in anti-microbial and chronic inflammation. The six IL-17 cytokines (IL-17A-F) are encoded by separate genes but adopt a conserved cystine knot fold (1, 2). Mature human IL-17A shares 60% amino acid sequence identity with mouse and rat IL-17A (3, 4). IL-17A is secreted by Th17 cells, gamma /δ T cells, iNKT cells, NK cells, LTi cells, neutrophils, and intestinal Paneth cells (2). It forms disulfide-linked homodimers as well as disulfide-linked heterodimers with IL-17F (5, 6). IL-17A exerts its effects through the transmembrane IL-17RA in complex with IL-17RC or IL-17RD (7, 8). Both IL-17RA and IL-17RC are required for responsiveness to heterodimeric IL-17A/F (7). IL-17A promotes protective mucosal and epidermal inflammation in response to microbial infection (9-12). It induces chemokine production, neutrophil influx, and the production of antibacterial peptides
(9-11). IL-17A/F likewise induces neutrophil migration, but IL-17F does not (11). IL-17A additionally enhances the production of inflammatory mediators by rheumatoid synovial fibroblasts and contributes to TNF-alpha induced shock (4, 13). In contrast, it can protect against the progression of colitis by limiting chronic inflammation (12). IL-17A encourages the formation of autoreactive germinal centers and exacerbates the onset and progression of experimental models of autoimmunity (14, 15).
IL-17A has been shown to exert either tumorigenic or anti-tumor effects (16, 17).
- Gaffen, S.L. (2009) Nat. Rev. Immunol. 9:556.
- Cua, D.J. and C.M. Tato (2010) Nat. Rev. Immunol. 10:479.
- Yao, Z. et al. (1995) J. Immunol. 155:5483.
- Fossiez, F. et al. (1996) J. Exp. Med. 183:2593.
- Chang, S.H. and C. Dong (2007) Cell Res. 17:435.
- Wright, J.F. et al. (2007) J. Biol. Chem. 282:13447.
- Wright, J.F. et al. (2008) J. Immunol. 181:2799.
- Rong, Z. et al. (2009) Cell Res. 19:208.
- Cho, J.S. et al. (2010) J. Clin. Invest. 120:1762.
- Liang, S.C. et al. (2006) J. Exp. Med. 203:2271.
- Liang, S.C. et al. (2007) J. Immunol. 179:7791.
- O’Connor Jr., W. et al. (2009) Nat. Immunol. 10:603.
- Takahashi, N. et al. (2008) J. Exp. Med. 205:1755.
- Hsu, H. et al. (2008) Nat. Immunol. 9:166.
- Rohn, T.A. et al. (2006) Eur. J. Immunol. 36:2857.
- Wang, L. et al. (2009) J. Exp. Med. 206:1457.
- Kryczek, I. et al. (2009) Blood 114:357.
Citation for Recombinant Human IL-17A, Biotinylated Protein
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
1 Citation: Showing 1 - 1
-
Identification and structure-based drug design of cell-active inhibitors of interleukin 17A at a novel C-terminal site
Authors: ER Goedken, MA Argiriadi, JD Dietrich, AM Petros, N Krishnan, SC Panchal, W Qiu, H Wu, H Zhu, AM Adams, PM Bodelle, L Goguen, PL Richardson, PF Slivka, M Srikumaran, AK Upadhyay, B Wu, RA Judge, A Vasudevan, SM Gopalakris, PB Cox, VS Stoll, C Sun
Scientific Reports, 2022-08-26;12(1):14561.
Species: Human
Sample Types: Recombinant Protein
Applications: Bioassay
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Human IL-17A, Biotinylated Protein
There are currently no reviews for this product. Be the first to review Recombinant Human IL-17A, Biotinylated Protein and earn rewards!
Have you used Recombinant Human IL-17A, Biotinylated Protein?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image